• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Eculizumab was safe and effective in the management of transplant-associated thrombotic microangiopathy in a heart transplant recipient with concurrent COVID-19 infection.

作者信息

Xu Chi, Wong Vincent, Kurniawan Ariefandi, Wilson Scott, Gopal Basu, Lawton Paul D

机构信息

Department of Renal Medicine, Alfred Health, Melbourne, Victoria, Australia.

Department of Renal Services, Western Health, Melbourne, Victoria, Australia.

出版信息

Intern Med J. 2023 Aug;53(8):1506-1508. doi: 10.1111/imj.16178.

DOI:10.1111/imj.16178
PMID:37599228
Abstract
摘要

相似文献

1
Eculizumab was safe and effective in the management of transplant-associated thrombotic microangiopathy in a heart transplant recipient with concurrent COVID-19 infection.依库珠单抗在一名合并新型冠状病毒肺炎感染的心脏移植受者的移植相关血栓性微血管病治疗中安全有效。
Intern Med J. 2023 Aug;53(8):1506-1508. doi: 10.1111/imj.16178.
2
Eculizumab therapy in adults with allogeneic hematopoietic cell transplant-associated thrombotic microangiopathy.依库珠单抗治疗异基因造血细胞移植相关血栓性微血管病的成人患者
Bone Marrow Transplant. 2016 Sep;51(9):1241-4. doi: 10.1038/bmt.2016.87. Epub 2016 Apr 11.
3
De novo thrombotic microangiopathy following simultaneous pancreas and kidney transplantation managed with eculizumab.接受依库珠单抗治疗的胰肾联合移植术后新发血栓性微血管病
Nephrology (Carlton). 2017 Feb;22 Suppl 1:23-27. doi: 10.1111/nep.12936.
4
Successful use of eculizumab in a patient with post-transplant thrombotic microangiopathy.依库珠单抗成功用于一名移植后血栓性微血管病患者。
Br J Haematol. 2013 Apr;161(2):279-80. doi: 10.1111/bjh.12202. Epub 2013 Jan 7.
5
Thrombotic microangiopathy: eculizumab for atypical haemolytic uraemic syndrome: what next?血栓性微血管病：依库珠单抗治疗非典型溶血性尿毒症综合征：下一步何去何从？
Nat Rev Nephrol. 2013 Sep;9(9):495-6. doi: 10.1038/nrneph.2013.150. Epub 2013 Aug 6.
6
Thrombotic Microangiopathy Triggered by COVID-19: Case Reports.新冠病毒引发血栓性微血管病：病例报告。
Nephron. 2022;146(2):197-202. doi: 10.1159/000520144. Epub 2021 Nov 22.
7
A case of thrombotic micro-angiopathy after heart transplantation successfully treated with eculizumab.1例心脏移植术后血栓性微血管病经依库珠单抗成功治疗。
Transpl Int. 2015 Jul;28(7):878-80. doi: 10.1111/tri.12551. Epub 2015 Mar 9.
8
Use of eculizumab in autologous hematopoietic stem cell transplantation-associated thrombotic microangiopathy in two adults.依库珠单抗在两名成人自体造血干细胞移植相关血栓性微血管病中的应用。
Leuk Lymphoma. 2022 Feb;63(2):473-477. doi: 10.1080/10428194.2021.1992625. Epub 2021 Oct 20.
9
The successful use of eculizumab for treatment of thrombotic microangiopathy in pediatric acute SARSCoV2 infection and multisystem inflammatory syndrome in children.依库珠单抗成功用于治疗儿童急性SARS-CoV-2感染中的血栓性微血管病及儿童多系统炎症综合征。
Haematologica. 2022 Oct 1;107(10):2517-2522. doi: 10.3324/haematol.2022.280603.
10
Thrombotic Microangiopathy as a Cause of Chronic Kidney Transplant Dysfunction: Case Report Demonstrating Successful Treatment with Eculizumab.血栓性微血管病作为慢性肾移植功能障碍的一个病因：一例使用依库珠单抗成功治疗的病例报告
Transplant Proc. 2015 Sep;47(7):2258-61. doi: 10.1016/j.transproceed.2015.08.004.